Webcode 25072002
Sèye Abogunrin
F. Hoffmann-La Roche Ltd, Switzerland
Global Access Evidence Lead Dr Seye Abogunrin is a Global Access Evidence Lead at Roche. In his role, Dr Abogunrinn is an HTA and technology innovation leader responsible for identifying and implementing AI and similar technologies for process optimization in matters related to market access, pricing, health economics and outcomes research at Roche. He is a disruptive technology-in-healthcare advocate and strategist with interests in artificial intelligence, extended reality and block-chain technologies.
Dr. Daniel Brand
SKC Beratungsgesellschaft mbH, Germany
Senior Medical Writer
Dr. Lydia Frick
SKC Beratungsgesellschaft mbH, Germany
Director Market Access
More information please click here.
Ronja Kerßenboom
Janssen-Cilag GmbH, Germany
Market Access Manager HTA Methods
Sian Tanner
IQVIA, The Netherlands
Principal, Advisory Lead - EU HTA Solutions
10/07/2025
10/07/2025
9:00 am - 5:00 pm seminar
You may dial in 30 minutes in advance
Veranstaltung - 1,290 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Veranstaltung - 1,290 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Dr. Henriette Wolf-Klein
Head of Department
+49 6221 500-680
h.wolf-klein@forum-institut.de
Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essential market access areas covered
In this course, you will learn how to leverage AI for clinical data evaluation, systematic literature reviews, dossier development, and PICO simulations.
Five industry experts will a.o. demonstrate use cases, highlighting both the benefits and limitations of AI - from clinical data evaluation to dossier submission. Additionally, they will focus on the day-to-day application of generative AI in market access.
By the end of this course, you will have a comprehensive understanding of AI’s potential and how to effectively implement it in your daily work.
09:00 Opening and participant expectations
09:20
Dr. Daniel Brand, Dr. Lydia Frick
10:40 Coffee break
11:00
Sèye Abogunrin
12:10 Lunch
13:20
Dr. Daniel Brand, Dr. Lydia Frick
14:20 Coffee break
14:40
Ronja Kerßenboom
15:40 Short break
15:50
Sian Tanner
17:00 Course end
You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.
We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.
of 5 stars of all ratings from 2024
of 5 stars on Trustpilot = good
Diese Fachtagung adressiert Neuerungen bei neuen Arzneimitteln, Generika und Biosimilars - im GKV-System und EU-weit. Hi...
Here you will get the latest information on the process of joint clinical assessments, including scoping and JCA dossier...
The online seminar with details on development, quality, CMC, approval and market access (including an update on the upc...
Welche Verhandlungsoptionen und Vertragsmodelle bestehen in der GKV - das Seminar gibt Ihnen Anregungen für Ihr Produkt!
Crashkurs Pharma Business Development - für Neu- und Quereinsteiger*innen
